Literature DB >> 6985473

The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA.

P Aleström, G Akusjärvi, M Perricaudet, M B Mathews, D F Klessig, U Pettersson.   

Abstract

A 606 base pair segment of adenovirus type 2 DNA which includes the gene for polypeptide IX and its flanking regions has been sequenced. Comparison with the sequence of a cDNA copy of the 9S mRNA for polypeptide IX and direct analysis of its capped oligonucleotide show that the gene and its mRNA are colinear. The 9S mRNA has a length of 485 nucleotides, excluding the poly(A) tract and the m7G of the cap, and contains one single open translational reading frame which is sufficiently long to encode polypeptide IX. This reading frame contains three AUG codons, the first of which is used for initiation of protein synthesis. The mRNA has a 5' noncoding region of 24 nucleotides, excluding the m5G of the cap, and encodes a polypeptide which is 139 amino acids long and unusually rich in serine and alanine. The sequence TATATAA is found 25 nucleotides upstream from the cap site. The polyadenylation site has been identified but cannot be located unambiguously because of the presence of two A residues in the DNA sequence at this position. The 3' noncoding region is 41--43 nucleotides long and contains the hexanucleotide sequence AAUAAA. The mRNA for polypeptide IVa2 is encoded adjacent to that for polypeptide IX and is transcribed in the opposite direction. Sequence analysis revealed an overlap of 11--16 nucleotides, depending on the precise location of the polyadenylation sites, between 3' ends of these mRNAs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6985473     DOI: 10.1016/s0092-8674(80)80044-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  74 in total

1.  The subgenus-specific C-terminal region of protein IX is located on the surface of the adenovirus capsid.

Authors:  A Akalu; H Liebermann; U Bauer; H Granzow; W Seidel
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  A novel type of splicing enhancer regulating adenovirus pre-mRNA splicing.

Authors:  O Mühlemann; B G Yue; S Petersen-Mahrt; G Akusjärvi
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization.

Authors:  M Rosa-Calatrava; L Grave; F Puvion-Dutilleul; B Chatton; C Kedinger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.

Authors:  M Molin; G Akusjärvi
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Transcription of adenovirus type 2 genes in a cell-free system: apparent heterogeneity of initiation at some promoters.

Authors:  D C Lee; R G Roeder
Journal:  Mol Cell Biol       Date:  1981-07       Impact factor: 4.272

6.  Molecular composition of the adenovirus type 2 virion.

Authors:  J van Oostrum; R M Burnett
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

7.  Promoter of the adenovirus polypeptide IX gene: similarity to E1B and inactivation by substitution of the simian virus 40 TATA element.

Authors:  L E Babiss; L D Vales
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  Early region 1B of adenovirus 2 encodes two coterminal proteins of 495 and 155 amino acid residues.

Authors:  C W Anderson; R C Schmitt; J E Smart; J B Lewis
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

9.  Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.

Authors:  S Fennewald; V van Santen; E Kieff
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

10.  Establishment and characterization of hamster cell lines transformed by restriction endonuclease fragments of adenovirus 5.

Authors:  D T Rowe; P E Branton; S P Yee; S Bacchetti; F L Graham
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.